U.S. Markets closed

Alkermes plc (ALKS)

NASDAQ Global Select - NASDAQ Global Select Delayed Price. Currency in USD
Add to watchlist
50.05-0.63 (-1.24%)
At close: 4:00PM EDT

50.06 +0.01 (0.01%)
After hours: 5:05PM EDT

People also watch
ALXNBMRNNBIXINCYVRTX
Full screen
Previous Close50.68
Open50.74
Bid31.09 x 100
Ask55.94 x 100
Day's Range50.02 - 50.94
52 Week Range41.93 - 63.40
Volume634,766
Avg. Volume805,343
Market Cap7.69B
Beta2.27
PE Ratio (TTM)-37.92
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Alkermes Initiates Rolling Submission of Depression Drug
    Zacks12 hours ago

    Alkermes Initiates Rolling Submission of Depression Drug

    Alkermes (ALKS) initiated the rolling submission of a New Drug Application (NDA) to the FDA for pipeline candidate ALKS 5461 for major depressive disorder.

  • See what the IHS Markit Score report has to say about Alkermes PLC.
    Markit15 hours ago

    See what the IHS Markit Score report has to say about Alkermes PLC.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding ALKS totaled $71 million.

  • See what the IHS Markit Score report has to say about Alkermes PLC.
    Markit7 days ago

    See what the IHS Markit Score report has to say about Alkermes PLC.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.